More than 3000 patients with breast cancer have received radiation with the Xoft System.
Specialty Pharmacy
Advertisement
Treatment with endostatin slowed the proliferation of resistant prostate cancer cells.
Advertisement
Eculizumab (Soliris) can reduce disease burden for patients with refractory generalized myasthenia gravis.
Top news of the day from across the health care landscape.
Epalrestat could prevent metastasis in patients with basal-like triple-negative breast cancer.
High consumption of isoflavones reduced all-cause mortality in patients with breast cancer by 21%.
Advertisement
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how specialty pharmacy can help patients manage high out of pocket costs for specialty drugs.
Niraparib (Zejula) FDA approved to treat epithelial ovarian, fallopian tube, or primary peritoneal cancers.
There is little room for error in the highly competitive specialty pharmacy landscape.
Findings open the door for new therapeutic options for myelin regeneration in multiple sclerosis.
Advertisement
Most models were cancer-free within 6 weeks of treatment with selenomab-drug conjugates.
New report reveals trends in the 8 major markets over the next decade.
Top news of the day from across the health care landscape.
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
Pharmacists can address barriers to treatment, engage with patients, and advocate for change at the community and federal levels.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top news of the week in oncology and cancer drug development.
Checkpoint inhibitors plus myeloid-derived suppressor cell inhibitors show promise as prostate cancer treatment.
Quiescent stem cells are dormant and are not impacted by cancer treatments.
Top five most popular articles this week on Specialty Pharmacy Times.
Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.
The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival in patients with breast cancer.
Study suggests Medicare reform to help patients predict monthly medication costs.
Researchers from the VA system examined how mail-order delivery of drugs affects their patients with HIV.
Bavencio (avelumab) is indicated to treat metastatic Merkel cell carcinoma.
New research indicates that high consumption of certain dairy products may either increase or decrease the risk of developing breast cancer, depending on the food.
Monthly and annual spending limits would likely benefit Part D enrollees.
Genentech’s $100,000 grant will fund a home-based telemedicine program.
Policies targeting both physicians and hospitals could reduce wasteful health care spending.
Mapping lung cancer cell interactions can unveil new targeted treatment techniques.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
2
Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Building a Pharmacist-Led Furoscix Workflow From Scratch
5